Publicaciones en colaboración con investigadores/as de Universidade da Coruña (370)

2024

  1. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

    Frontiers in Pharmacology, Vol. 15

  2. Anti-Inflammatory Activity of APPA (Apocynin and Paeonol) in Human Articular Chondrocytes

    Pharmaceuticals, Vol. 17, Núm. 1

  3. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

    Seminars in Arthritis and Rheumatism, Vol. 65

  4. Delphi consensus on the use of telemedicine in rheumatology: RESULTAR study

    Reumatologia Clinica, Vol. 20, Núm. 5, pp. 254-262

  5. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

    Rheumatology International, Vol. 44, Núm. 11, pp. 2445-2455

  6. Evolution and advancements in genomics and epigenomics in OA research: How far we have come

    Osteoarthritis and Cartilage

  7. Fluctuation of Bone Marrow Lesions and Inflammatory MRI Markers over 2 Years and Concurrent Associations with Quantitative Cartilage Loss

    Cartilage

  8. Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis

    Rheumatology, Vol. 63, Núm. 11, pp. 3106-3114

  9. Metabolic syndrome is not associated with erosive hand osteoarthritis: a cross-sectional study using data from the PROCOAC cohort

    Scientific Reports, Vol. 14, Núm. 1

  10. Mitochondrial Role on Cellular Apoptosis, Autophagy, and Senescence during Osteoarthritis Pathogenesis

    Cells, Vol. 13, Núm. 11

  11. Mitonuclear epistasis involving TP63 and haplogroup Uk: Risk of rapid progression of knee OA in patients from the OAI

    Osteoarthritis and Cartilage, Vol. 32, Núm. 5, pp. 526-534

  12. Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis

    Pharmaceuticals, Vol. 17, Núm. 9

  13. Prognostic model to predict the incidence of radiographic knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 5, pp. 661-668

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. An Atlas of the Knee Joint Proteins and Their Role in Osteoarthritis Defined by Literature Mining

    Molecular and Cellular Proteomics, Vol. 22, Núm. 8

  3. Anti-inflammatory potential of ulvan

    International Journal of Biological Macromolecules, Vol. 253

  4. Epigenetics as a Therapeutic Target in Osteoarthritis

    Pharmaceuticals, Vol. 16, Núm. 2

  5. Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial

    Journal of Rheumatology, Vol. 50, Núm. 4, pp. 478-487

  6. Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

    Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115

  7. Generation of human immortalized chondrocytes from osteoarthritic and healthy cartilage A NEW TOOL FOR CARTILAGE PATHOPHYSIOLOGY STUDIES

    Bone and Joint Research, Vol. 12, Núm. 1, pp. 46-57